Literature DB >> 20804820

Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.

D Boido1, P Farisello, F Cesca, E Ferrea, F Valtorta, F Benfenati, P Baldelli.   

Abstract

Synapsins (SynI, SynII, SynIII) are a multigene family of synaptic vesicle (SV) phosphoproteins implicated in the regulation of synaptic transmission and plasticity. Synapsin I, II, I/II and I/II/III knockout mice are epileptic and SYN1/2 genes have been identified as major epilepsy susceptibility genes in humans. We analyzed cortico-hippocampal epileptiform activity induced by 4-aminopyridine (4AP) in acute slices from presymptomatic (3-weeks-old) and symptomatic (1-year-old) Syn I/II/III triple knockout (TKO) mice and aged-matched triple wild type (TWT) controls and assessed the effect of the SV-targeted antiepileptic drug (AED) levetiracetam (LEV) in reverting the epileptic phenotype. Both fast and slow interictal (I-IC) and ictal (IC) events were observed in both genotypes. The incidence of fast I-IC events was higher in presymptomatic TKO slices, while frequency and latency of I-IC events were similar in both genotypes. The major age and genotype effects were observed in IC activity, that was much more pronounced in 3-weeks-old TKO and persisted with age, while it disappeared from 1-year-old TWT slices. LEV virtually suppressed fast I-IC and IC discharges from 3-weeks-old TWT slices, while it only increased the latency of fast I-IC and IC activity in TKO slices. Analysis of I-IC events in patch-clamped CA1 pyramidal neurons revealed that LEV increased the inhibitory/excitatory ratio of I-IC activity in both genotypes. The lower LEV potency in TKO slices of both ages was associated with a decreased expression of SV2A, a SV protein acting as LEV receptor, in cortex and hippocampus. The results demonstrate that deletion of Syn genes is associated with a higher propensity to 4AP-induced epileptic paroxysms that precedes the onset of epilepsy and consolidates with age. LEV ameliorates such hyper excitability by enhancing the inhibition/excitation ratio, although the effect is hindered in TKO slices which exhibit a concomitant decrease in the levels of the LEV receptor SV2A.
Copyright © 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804820     DOI: 10.1016/j.neuroscience.2010.08.046

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Synapsin II Regulation of GABAergic Synaptic Transmission Is Dependent on Interneuron Subtype.

Authors:  Pedro Feliciano; Heidi Matos; Rodrigo Andrade; Maria Bykhovskaia
Journal:  J Neurosci       Date:  2017-01-13       Impact factor: 6.167

2.  Growth and excitability at synapsin II deficient hippocampal neurons.

Authors:  Heidi Matos; Raymond Quiles; Rodrigo Andrade; Maria Bykhovskaia
Journal:  Mol Cell Neurosci       Date:  2019-03-09       Impact factor: 4.314

3.  Human glioma cells induce hyperexcitability in cortical networks.

Authors:  Susan L Campbell; Susan C Buckingham; Harald Sontheimer
Journal:  Epilepsia       Date:  2012-06-18       Impact factor: 5.864

4.  Synapsin II and Rab3a cooperate in the regulation of epileptic and synaptic activity in the CA1 region of the hippocampus.

Authors:  Pedro Feliciano; Rodrigo Andrade; Maria Bykhovskaia
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

5.  Large-scale, high-resolution electrophysiological imaging of field potentials in brain slices with microelectronic multielectrode arrays.

Authors:  E Ferrea; A Maccione; L Medrihan; T Nieus; D Ghezzi; P Baldelli; F Benfenati; L Berdondini
Journal:  Front Neural Circuits       Date:  2012-11-14       Impact factor: 3.492

6.  Epilepsy caused by an abnormal alternative splicing with dosage effect of the SV2A gene in a chicken model.

Authors:  Marine Douaud; Katia Feve; Fabienne Pituello; David Gourichon; Simon Boitard; Eric Leguern; Gérard Coquerelle; Agathe Vieaud; Cesira Batini; Robert Naquet; Alain Vignal; Michèle Tixier-Boichard; Frédérique Pitel
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

7.  Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics and short-term plasticity.

Authors:  Gabriele Lignani; Andrea Raimondi; Enrico Ferrea; Anna Rocchi; Francesco Paonessa; Fabrizia Cesca; Marta Orlando; Tatiana Tkatch; Flavia Valtorta; Patrick Cossette; Pietro Baldelli; Fabio Benfenati
Journal:  Hum Mol Genet       Date:  2013-02-12       Impact factor: 6.150

8.  Nonsense-mediated mRNA decay and loss-of-function of the protein underlie the X-linked epilepsy associated with the W356× mutation in synapsin I.

Authors:  Maila Giannandrea; Fabrizia C Guarnieri; Niels H Gehring; Elena Monzani; Fabio Benfenati; Andreas E Kulozik; Flavia Valtorta
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

9.  Autism-related behavioral abnormalities in synapsin knockout mice.

Authors:  Barbara Greco; Francesca Managò; Valter Tucci; Hung-Teh Kao; Flavia Valtorta; Fabio Benfenati
Journal:  Behav Brain Res       Date:  2012-12-29       Impact factor: 3.332

10.  Temporal evolution of neurophysiological and behavioral features of synapsin I/II/III triple knock-out mice.

Authors:  Marco Cambiaghi; Marco Cursi; Elena Monzani; Fabio Benfenati; Giancarlo Comi; Fabio Minicucci; Flavia Valtorta; Letizia Leocani
Journal:  Epilepsy Res       Date:  2012-07-28       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.